Supreme Court Holds Warning Claims
Against Generic Drug Manufacturers Are Preempted - Product Liability Update
Not exact matches
A recent Supreme Court ruling is limiting court actions by injured patients who have filed claims
against manufacturers of
generic drugs.
Specifically, in Rafferty v. Merck & Co., Inc., [4] the SJC held that plaintiffs who ingest the
generic form of a
drug may bring failure to warn claims
against the brand - name
manufacturer of the
drug if the brand - name defendant acted recklessly by «intentionally fail [ing] to update the label on its
drug while knowing or having reason to know of an unreasonable risk of death or grave bodily injury associated with its use.»
«Any recognition of an outlier theory of liability permitting a
generic drug consumer to bring an action
against the brand
manufacturer for an injury allegedly arising from the use of the
generic drug would be plainly at odds with this public policy.»